TickerLeague.com
Incyte Corporation logo

Incyte

INCY

Healthcare
NASDAQ
US
CIK:0000879169

About Incyte

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis a…

Power Profile

Revenue Counter

Incyte earns $163.03/sec (TTM: $5.14B)

Revenue counter

Earnings Counter

Incyte earns $40.80/sec net profit (TTM: $1.29B)

Earnings counter

Economic Scale

Incyte revenue exceeds Eswatini GDP ($4.9B)

Economic scale

What If Invested

See what $1,000 invested in Incyte would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Incyte generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Incyte

View seasonality
Q1 2026
Report Date
Apr 28, 2026
BMO
Lock in
41 days 4 hours
Revenue
Analyst Forecast
$1.25B
EPS
Analyst Forecast
1.41